A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.
The best Bull and Bear pitches based on recency and number of recommendations.
Let’s face it, investing in drug developers isn’t easy. First, there’s the science risk – the chance that the company’s best drug prospect will fail somewhere during the arduous clinical trial and regulatory approval process. If that weren’t enough,… More
Read the most recent pitches from players about CVD.DL.
Find the members with the highest scoring picks in CVD.DL.
See what the Wall Street professionals think, according to their public statements and filings.